Aquestive Therapeutics News

Aquestive Therapeutics (AQST.US) was first covered by Leerink Partners, which gave it an superior market rating and a target price of $8.00.

Zhitong FinanceMay 10 14:02

Aquestive Therapeutics Analyst Ratings

BenzingaMay 10 13:58

Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target

MT NewswiresMay 10 06:11

Buy Rating Justified for Aquestive Therapeutics Amidst Innovative Allergy Treatment and Strong Financial Prospects

TipRanksMay 10 05:39

Aquestive Therapeutics Analyst Ratings

BenzingaMay 9 06:19

Analysts Offer Insights on Healthcare Companies: LENZ Therapeutics (LENZ), MannKind (MNKD) and Aquestive Therapeutics (AQST)

TipRanksMay 9 05:50

Buy Rating Affirmed for Aquestive Therapeutics Amid Solid Finances and Promising Anaphylm Prospects

TipRanksMay 9 05:39

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Palatin Technologies (PTN)

TipRanksMay 8 11:20

Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)

TipRanksMay 8 08:01

Aquestive Therapeutics Analyst Ratings

BenzingaApr 30 05:30

Aquestive Therapeutics Earns Buy Rating on Libervant's Pediatric Approval and Anaphylm's Market Potential

TipRanksApr 30 05:18

Lake Street Sticks to Its Buy Rating for Aquestive Therapeutics (AQST)

TipRanksApr 29 07:55

Buy Rating Affirmed for Aquestive Therapeutics Following FDA Approval and Growth Prospects

TipRanksApr 28 23:25

Aquestive Therapeutics (AQST.US) was first covered by Piper Sandler, which gave it an incremental rating, with a target price of $10.00.

Zhitong FinanceApr 11 05:01

Aquestive Therapeutics Analyst Ratings

BenzingaApr 11 04:53

Piper Sandler Initiates Coverage On Aquestive Therapeutics With Overweight Rating, Announces Price Target of $10

BenzingaApr 11 04:54

Analysts Offer Insights on Healthcare Companies: EFFECTOR Therapeutics (EFTR), Adagene (ADAG) and Aquestive Therapeutics (AQST)

TipRanksApr 5 05:30

Aquestive Therapeutics Analyst Ratings

BenzingaApr 5 05:07

HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $9 Price Target

BenzingaApr 5 05:09

Aquestive Therapeutics Analyst Ratings

BenzingaMar 28 06:09